InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Krishnan Mahesh. Officer active across 2 companies, notably Chinook Therapeutics, INC.. Aggregated, 6 reports have been published. Split: 0 buy · 1 sell. Activity tracked since 25 April 2024. The latest transaction was disclosed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Krishnan Mahesh is a declarant linked to Halozyme Therapeutics, INC. and Chinook Therapeutics, INC., where he is listed as Director. The record shows 6 filings in total, and the recent filings covered run from 2023-04-04 to 2026-06-30. The modal transaction nature is Option exercise, and the cumulative buy and sell amounts for the recent sample are both 0.